Quick answers
- What is Lumryz?
- Lumryz is a brand name of Sodium oxybate, a prescription medicine. The FDA NDC Directory lists 4 Lumryz products in 4 strengths and forms.
- Who makes Lumryz?
- Alkermes Inc holds the FDA application for Lumryz (NDA214755, approved May 1, 2023).
- Is there a generic or store brand of Lumryz?
- Other products of Sodium oxybate are listed with the FDA, but none in exactly the same strength and form as a Lumryz product.
- Has Lumryz been recalled?
- No recall linked to Lumryz products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Lumryz is
Each Lumryz product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Sodium oxybate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| sodium oxybate 4.5 g for suspension, extended release (oral) | Lumryz | None listed | — |
| sodium oxybate 6 g for suspension, extended release (oral) | Lumryz | None listed | — |
| sodium oxybate 7.5 g for suspension, extended release (oral) | Lumryz | None listed | — |
| sodium oxybate 9 g for suspension, extended release (oral) | Lumryz | None listed | — |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Sodium oxybate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA214755 | Alkermes Inc | May 1, 2023 | 4 |
Companies that list Lumryz
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Lumryz products.
- Alkermes, Inc.4 products
Recalls
No recall linked to Lumryz products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.